128 related articles for article (PubMed ID: 8997280)
1. Pulmonary vascular pressure effects by endothelin-1 in normoxia and chronic hypoxia: a longitudinal study.
Tjen-A-Looi S; Ekman R; Osborn J; Keith I
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2246-53. PubMed ID: 8997280
[TBL] [Abstract][Full Text] [Related]
2. Three-week neonatal hypoxia reduces blood CGRP and causes persistent pulmonary hypertension in rats.
Keith IM; Tjen-A-Looi S; Kraiczi H; Ekman R
Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1571-8. PubMed ID: 11009443
[TBL] [Abstract][Full Text] [Related]
3. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat.
Oparil S; Chen SJ; Meng QC; Elton TS; Yano M; Chen YF
Am J Physiol; 1995 Jan; 268(1 Pt 1):L95-100. PubMed ID: 7840234
[TBL] [Abstract][Full Text] [Related]
4. CGRP and somatostatin modulate chronic hypoxic pulmonary hypertension.
Tjen-A-Looi S; Ekman R; Lippton H; Cary J; Keith I
Am J Physiol; 1992 Sep; 263(3 Pt 2):H681-90. PubMed ID: 1357980
[TBL] [Abstract][Full Text] [Related]
5. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
6. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist.
Li X; Liu KL; Zheng JQ; Chi MG; Dong JJ; Dong SJ; Gong ZH
Pulm Pharmacol Ther; 2008 Oct; 21(5):780-7. PubMed ID: 18602014
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs.
Muramatsu M; Rodman DM; Oka M; McMurtry IF
Am J Physiol; 1997 May; 272(5 Pt 1):L807-12. PubMed ID: 9176242
[TBL] [Abstract][Full Text] [Related]
9. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.
DiCarlo VS; Chen SJ; Meng QC; Durand J; Yano M; Chen YF; Oparil S
Am J Physiol; 1995 Nov; 269(5 Pt 1):L690-7. PubMed ID: 7491990
[TBL] [Abstract][Full Text] [Related]
10. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
11. Acute alveolar hypoxia increases endothelin-1 release but decreases release of calcitonin gene-related peptide in isolated perfused rat lungs.
Helset E; Kjaeve J; Bjertnaes L; Lundberg JM
Scand J Clin Lab Invest; 1995 Aug; 55(5):369-76. PubMed ID: 8545594
[TBL] [Abstract][Full Text] [Related]
12. BQ123, an ETA-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats.
Bonvallet ST; Zamora MR; Hasunuma K; Sato K; Hanasato N; Anderson D; Sato K; Stelzner TJ
Am J Physiol; 1994 Apr; 266(4 Pt 2):H1327-31. PubMed ID: 8184910
[TBL] [Abstract][Full Text] [Related]
13. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
[TBL] [Abstract][Full Text] [Related]
14. [Effects of endothelin receptor antagonist on the hypoxic pulmonary hypertension].
Chen W; Cheng D
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):370-2, 386. PubMed ID: 12545837
[TBL] [Abstract][Full Text] [Related]
15. Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet.
Gosselin R; Gutkowska J; Baribeau J; Perreault T
Am J Physiol; 1997 Jul; 273(1 Pt 1):L72-9. PubMed ID: 9252542
[TBL] [Abstract][Full Text] [Related]
16. Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs.
Takeoka M; Ishizaki T; Sakai A; Chang SW; Shigemori K; Higashi T; Ueda G
Acta Physiol Scand; 1995 Sep; 155(1):53-60. PubMed ID: 8553877
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
18. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S
J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651
[TBL] [Abstract][Full Text] [Related]
19. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Ivy DD; Kinsella JP; Abman SH
J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
[TBL] [Abstract][Full Text] [Related]
20. Effects of nifedipine-induced pulmonary vasodilatation on cardiac receptors and protein kinase C isoforms in the chronically hypoxic rat.
Morel OE; Buvry A; Le Corvoisier P; Tual L; Favret F; León-Velarde F; Crozatier B; Richalet JP
Pflugers Arch; 2003 Jun; 446(3):356-64. PubMed ID: 12715180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
